Robert Chess Nektar Therapeutics (NKTR) insider trading activity

Robert Chess is of NEKTAR THERAPEUTICS. Currently has a direct ownership of 255,273 shares of NKTR, which is worth approximately $255,273. The most recent transaction as insider was on Jun 14, 2024, when has been sold 19,500 shares (Common Stock) at a price of $1.2 per share, resulting in proceeds of $23,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 255K

0% 3M change

7.1% 12M change

Total Value Held $255,273

ROBERT CHESS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 14 2024	SELL Open market or private sale	$23,400 $1.2 p/Share	19,500 Reduced 7.1%	255,273 Common Stock
Sep 22 2022	SELL Open market or private sale	$6,834 $0.67 p/Share	10,200 Reduced 3.58%	274,773 Common Stock
Sep 22 2022	SELL Open market or private sale	$16,269 $3.19 p/Share	5,100 Reduced 2.19%	228,179 Common Stock
Sep 16 2022	BUY Grant, award, or other acquisition	-	10,200 Added 4.19%	233,279 Common Stock
Sep 22 2021	SELL Open market or private sale	$82,524 $17.94 p/Share	4,600 Reduced 1.62%	279,873 Common Stock
Sep 22 2021	BUY Grant, award, or other acquisition	-	10,200 Added 3.46%	284,473 Common Stock
Sep 09 2021	SELL Open market or private sale	$164,670 $16.02 p/Share	10,279 Reduced 3.61%	274,273 Common Stock
Sep 09 2021	BUY Exercise of conversion of derivative security	$141,850 $13.8 p/Share	10,279 Added 3.49%	284,552 Common Stock
Sep 08 2021	SELL Open market or private sale	$128,000 $16.0 p/Share	8,000 Reduced 2.83%	274,273 Common Stock
Sep 08 2021	BUY Exercise of conversion of derivative security	$110,400 $13.8 p/Share	8,000 Added 2.76%	282,273 Common Stock
Aug 24 2021	SELL Bona fide gift	-	6,300 Reduced 2.25%	274,273 Common Stock
Jul 22 2021	SELL Open market or private sale	$1,529 $16.8 p/Share	91 Reduced 0.03%	280,573 Common Stock
Jul 22 2021	BUY Exercise of conversion of derivative security	$1,256 $13.8 p/Share	91 Added 0.03%	280,664 Common Stock
Jul 21 2021	SELL Open market or private sale	$59,238 $16.81 p/Share	3,524 Reduced 1.24%	280,573 Common Stock
Jul 21 2021	BUY Exercise of conversion of derivative security	$48,631 $13.8 p/Share	3,524 Added 1.23%	284,097 Common Stock
Jul 20 2021	SELL Open market or private sale	$35,381 $16.8 p/Share	2,106 Reduced 0.75%	280,573 Common Stock
Jul 20 2021	BUY Exercise of conversion of derivative security	$29,063 $13.8 p/Share	2,106 Added 0.74%	282,679 Common Stock
May 12 2021	SELL Open market or private sale	$154,720 $19.34 p/Share	8,000 Reduced 2.77%	280,573 Common Stock
May 12 2021	BUY Exercise of conversion of derivative security	$110,400 $13.8 p/Share	8,000 Added 2.7%	288,573 Common Stock
Apr 14 2021	SELL Open market or private sale	$151,840 $18.98 p/Share	8,000 Reduced 2.77%	280,573 Common Stock
Apr 14 2021	BUY Exercise of conversion of derivative security	$110,400 $13.8 p/Share	8,000 Added 2.7%	288,573 Common Stock

Also insider at

TWST

Twist Bioscience Corp Healthcare

Robert Chess

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NKTR shares.

Notify only if

Value

Insider Trading

Get notified when an Nektar Therapeutics insider buys or sells NKTR shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEKTAR THERAPEUTICS

Track Activities on NKTR

Account